<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02041546</url>
  </required_header>
  <id_info>
    <org_study_id>ZTB0607</org_study_id>
    <nct_id>NCT02041546</nct_id>
  </id_info>
  <brief_title>Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome</brief_title>
  <official_title>Zekai Tahir Burak Maternity Teaching Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <brief_summary>
    <textblock>
      Meconium aspiration syndrome (MAS) is an important cause of severe respiratory failure in
      newborn infants. Treatment for MAS is mainly supportive but surfactant therapy might change
      the course of the disease. Aim of the study to evaluate whether lung lavage with dilute or
      bolus poractant alfa changes the duration of mechanical respiratory support or other outcomes
      in MAS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Total duration of mechanical ventilation, mode and ventilator parameters are noted till the baby is on mechanical ventilation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>Incidence of Persistent Pulmonary Hypertension by Echocardiography and Pneumothorax by transillumination confirmed by chest x-ray.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hospital Stay</measure>
    <time_frame>Up to 8 weeks or till discharge</time_frame>
    <description>We will record length of stay in a level III neonatal intensive care unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Up to 3 months or till discharge</time_frame>
    <description>We will record who died until discharge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Meconium Aspiration Syndrome</condition>
  <arm_group>
    <arm_group_label>Bolus surfactant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bolus surfactant 100 mg/kg proctant alfa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lung lavage with surfactant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lung lavage with surfactant</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lung lavage with surfactant</intervention_name>
    <arm_group_label>Lung lavage with surfactant</arm_group_label>
    <other_name>Poractant alfa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bolus surfactant</intervention_name>
    <arm_group_label>Bolus surfactant</arm_group_label>
    <other_name>Poractant alfa</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants with a gestational age ≥ 36 weeks, birth weight ≥ 2.0 kg, evidence of passage
             of meconium at or before delivery, typical chest radiology findings and mechanically
             ventilated infants with a mean airway pressure ≥ 12 cm H2O were enrolled.

        Exclusion Criteria:

          -  Congenital cardiac anomalies

          -  Major congenital anomalies

          -  Hemodynamically unstable infants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2014</study_first_submitted>
  <study_first_submitted_qc>January 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2014</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Yekta</investigator_full_name>
    <investigator_title>Zekai Tahir Burak Maternity and Teaching Hospital</investigator_title>
  </responsible_party>
  <keyword>Lung lavage,</keyword>
  <keyword>Surfactant,</keyword>
  <keyword>Duration of mechanical</keyword>
  <keyword>ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Meconium Aspiration Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
    <mesh_term>Poractant alfa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

